Humacyte (HUMA) Current Leases (2020 - 2026)

Humacyte (HUMA) has reported Current Leases for 7 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases fell 50.92% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 50.92% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 16.76% from the prior year.
• Current Leases was $1.5 million for Q2 2026 at Humacyte, down from $2.4 million in the prior quarter.
• Over five years, Current Leases peaked at $3.1 million in Q2 2025 and troughed at $1.5 million in Q2 2026.
• A 5-year average of $2.5 million and a median of $2.5 million in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases gained 14.34% in 2024 and slumped 50.92% in 2026, its largest moves.
• Over 5 years, Current Leases stood at $2.3 million in 2022, then grew by 13.48% to $2.6 million in 2023, then advanced by 13.95% to $2.9 million in 2024, then slipped by 16.76% to $2.4 million in 2025, then tumbled by 37.48% to $1.5 million in 2026.
• The last three Current Leases figures came in at $1.5 million (Q2 2026), $2.4 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.